| Title |
Denosumab significantly increases bone mineral density and reduces bone turnover compared with monthly oral ibandronate and risedronate in postmenopausal women who remained at higher risk for fracture despite previous suboptimal treatment with an oral bisphosphonate
|
|---|---|
| Published in |
Osteoporosis International, March 2014
|
| DOI | 10.1007/s00198-014-2692-7 |
| Pubmed ID | |
| Authors |
J. P. Brown, C. Roux, P. R. Ho, M. A. Bolognese, J. Hall, H. G. Bone, S. Bonnick, J. P. van den Bergh, I. Ferreira, P. Dakin, R. B. Wagman, C. Recknor |
| Abstract |
Managing osteoporotic patients suboptimally adherent to bisphosphonates (BPs) is difficult. Such patients who remained at higher risk for fracture (≥1 risk factor) were transitioned to denosumab or a monthly oral BP. Denosumab-treated subjects had significantly greater increases in bone mineral density and decreases in bone turnover in this 12-month study. |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 25% |
| South Africa | 1 | 25% |
| Netherlands | 1 | 25% |
| Unknown | 1 | 25% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 75% |
| Scientists | 1 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 99 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 1% |
| United States | 1 | 1% |
| Unknown | 97 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 19 | 19% |
| Student > Master | 15 | 15% |
| Other | 9 | 9% |
| Student > Ph. D. Student | 9 | 9% |
| Student > Bachelor | 7 | 7% |
| Other | 24 | 24% |
| Unknown | 16 | 16% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 53 | 54% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 6% |
| Agricultural and Biological Sciences | 2 | 2% |
| Psychology | 2 | 2% |
| Engineering | 2 | 2% |
| Other | 6 | 6% |
| Unknown | 28 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 May 2015.
All research outputs
#14,194,875
of 22,753,345 outputs
Outputs from Osteoporosis International
#2,119
of 3,603 outputs
Outputs of similar age
#118,661
of 224,802 outputs
Outputs of similar age from Osteoporosis International
#47
of 91 outputs
Altmetric has tracked 22,753,345 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,603 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one is in the 39th percentile – i.e., 39% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 224,802 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 91 others from the same source and published within six weeks on either side of this one. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.